BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 24904823)

  • 1. Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumor microenvironment.
    Mockler MB; Conroy MJ; Lysaght J
    Front Oncol; 2014; 4():107. PubMed ID: 24904823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate and Adaptive Immune Cell Metabolism in Tumor Microenvironment.
    Wu D
    Adv Exp Med Biol; 2017; 1011():211-223. PubMed ID: 28875492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovering the strength of immunometabolism in cancer therapy: Employing metabolic pathways to enhance immune responses.
    Huldani H; Malviya J; Rodrigues P; Hjazi A; Deorari MM; Al-Hetty HRAK; Qasim QA; Alasheqi MQ; Ihsan A
    Cell Biochem Funct; 2024 Mar; 42(2):e3934. PubMed ID: 38379261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunometabolism and Its Potential to Improve the Current Limitations of Immunotherapy.
    Sheppard AD; Lysaght J
    Methods Mol Biol; 2020; 2184():233-263. PubMed ID: 32808230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Regulation of T cell Activity: Implications for Metabolic-Based T-cell Therapies for Cancer.
    Abdesheikhi J; Sedghy F; Mahmoodi M; Fallah H; Ranjkesh M
    Iran Biomed J; 2023 Jan; 27(1):1-14. PubMed ID: 36624636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy.
    Yin Z; Bai L; Li W; Zeng T; Tian H; Cui J
    J Exp Clin Cancer Res; 2019 Sep; 38(1):403. PubMed ID: 31519198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy.
    Lim AR; Rathmell WK; Rathmell JC
    Elife; 2020 May; 9():. PubMed ID: 32367803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunometabolism: A new target for improving cancer immunotherapy.
    Guo C; Chen S; Liu W; Ma Y; Li J; Fisher PB; Fang X; Wang XY
    Adv Cancer Res; 2019; 143():195-253. PubMed ID: 31202359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.
    Bahrambeigi S; Shafiei-Irannejad V
    Biochem Pharmacol; 2020 Apr; 174():113787. PubMed ID: 31884044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic regulation of immune responses to cancer.
    Wißfeld J; Werner A; Yan X; Ten Bosch N; Cui G
    Cancer Biol Med; 2022 Oct; 19(11):1528-42. PubMed ID: 36269001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunometabolism in cancer: basic mechanisms and new targeting strategy.
    Su R; Shao Y; Huang M; Liu D; Yu H; Qiu Y
    Cell Death Discov; 2024 May; 10(1):236. PubMed ID: 38755125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic reprogramming by miRNAs in the tumor microenvironment: Focused on immunometabolism.
    Alshahrani SH; Ibrahim YS; Jalil AT; Altoum AA; Achmad H; Zabibah RS; Gabr GA; Ramírez-Coronel AA; Alameri AA; Qasim QA; Karampoor S; Mirzaei R
    Front Oncol; 2022; 12():1042196. PubMed ID: 36483029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell immunometabolism against cancer.
    Jiang S; Yan W
    Cancer Lett; 2016 Nov; 382(2):255-258. PubMed ID: 27664755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.
    Nachef M; Ali AK; Almutairi SM; Lee SH
    Front Immunol; 2021; 12():624324. PubMed ID: 33953707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune and metabolic checkpoints blockade: Dual wielding against tumors.
    Kazemi MH; Najafi A; Karami J; Ghazizadeh F; Yousefi H; Falak R; Safari E
    Int Immunopharmacol; 2021 May; 94():107461. PubMed ID: 33592403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the Complex Interplay Between T Cell Metabolism and Function.
    Geltink RIK; Kyle RL; Pearce EL
    Annu Rev Immunol; 2018 Apr; 36():461-488. PubMed ID: 29677474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic dialogs between B cells and the tumor microenvironment: Implications for anticancer immunity.
    Jiang S; Feng R; Tian Z; Zhou J; Zhang W
    Cancer Lett; 2023 Mar; 556():216076. PubMed ID: 36724837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic regulation of regulatory T cell development and function.
    Coe DJ; Kishore M; Marelli-Berg F
    Front Immunol; 2014; 5():590. PubMed ID: 25477880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunometabolism: Cellular Metabolism Turns Immune Regulator.
    Loftus RM; Finlay DK
    J Biol Chem; 2016 Jan; 291(1):1-10. PubMed ID: 26534957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of FABP5 in T Cell Lipid Metabolism and Function in the Tumor Microenvironment.
    Jin R; Hao J; Yu J; Wang P; Sauter ER; Li B
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.